Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | glutaminase | 0.0269 | 0.2665 | 0.2586 |
Loa Loa (eye worm) | glutaminase 2 | 0.0269 | 0.2665 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0099 | 0.0803 | 0.2715 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0036 | 0.0109 | 0.4754 |
Schistosoma mansoni | alpha-glucosidase | 0.0138 | 0.123 | 0.4384 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0939 | 1 | 0.5 |
Echinococcus multilocularis | tumor protein p63 | 0.0676 | 0.7121 | 0.8404 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0047 | 0.0239 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0047 | 0.0239 | 0.1374 |
Leishmania major | trypanothione reductase | 0.0047 | 0.0229 | 0.9576 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0047 | 0.0239 | 0.0133 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0107 | 0.0403 |
Toxoplasma gondii | thioredoxin reductase | 0.0047 | 0.0229 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0047 | 0.0239 | 0.0895 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0106 | 0.0881 | 0.0802 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.1054 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0047 | 0.0229 | 0.0229 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.1054 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.0269 | 0.2665 | 1 |
Onchocerca volvulus | 0.0099 | 0.0803 | 1 | |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0106 | 0.0881 | 0.0802 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0939 | 1 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0106 | 0.0881 | 0.0802 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.016 | 0.1474 | 0.553 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0118 | 0.1011 | 0.0932 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0047 | 0.0239 | 0.0133 |
Trypanosoma brucei | glucosidase, putative | 0.0036 | 0.0109 | 0.4754 |
Brugia malayi | glutathione reductase | 0.0047 | 0.0229 | 0.0857 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0036 | 0.0109 | 0.4553 |
Brugia malayi | AMP-binding enzyme family protein | 0.0047 | 0.0239 | 0.0895 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.0239 | 0.0895 |
Brugia malayi | glutaminase DH11.1 | 0.0269 | 0.2665 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0107 | 0.0403 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0047 | 0.0239 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0029 | 0.0039 | 0.0147 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.0239 | 0.0895 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0118 | 0.1011 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0047 | 0.0229 | 0.0229 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0035 | 0.0107 | 0.0107 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.016 | 0.1474 | 0.553 |
Schistosoma mansoni | glutaminase | 0.0269 | 0.2665 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.1054 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0939 | 1 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0047 | 0.0239 | 0.0154 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.016 | 0.1474 | 0.1947 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0047 | 0.0229 | 0.0857 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.1054 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.0138 | 0.123 | 0.4384 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0047 | 0.0239 | 0.0133 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0047 | 0.0239 | 0.0133 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0939 | 1 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0036 | 0.0109 | 0.0408 |
Plasmodium falciparum | thioredoxin reductase | 0.0047 | 0.0229 | 0.0229 |
Loa Loa (eye worm) | glutathione reductase | 0.0047 | 0.0229 | 0.0857 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0107 | 0.0403 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0047 | 0.0239 | 0.1374 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0939 | 1 | 1 |
Loa Loa (eye worm) | glutaminase | 0.0269 | 0.2665 | 1 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0106 | 0.0881 | 0.8321 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0107 | 0.0403 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0047 | 0.0229 | 0.0144 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0803 | 0.3012 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0047 | 0.0239 | 0.0133 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0106 | 0.0881 | 0.0802 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0047 | 0.0239 | 0.0133 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0047 | 0.0229 | 0.0144 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.016 | 0.1474 | 0.1636 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0036 | 0.0109 | 0.0408 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0939 | 1 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.016 | 0.1474 | 0.1636 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0047 | 0.0229 | 0.0171 |
Mycobacterium tuberculosis | Probable reductase | 0.0106 | 0.0881 | 0.0802 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0118 | 0.1011 | 0.0932 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0036 | 0.0109 | 0.4754 |
Brugia malayi | AMP-binding enzyme family protein | 0.0047 | 0.0239 | 0.0895 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.0239 | 0.0895 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0118 | 0.1011 | 0.0932 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0798 | 0.8452 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0107 | 0.0403 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0047 | 0.0239 | 0.0154 |
Brugia malayi | Thioredoxin reductase | 0.0047 | 0.0229 | 0.0857 |
Plasmodium falciparum | glutathione reductase | 0.0047 | 0.0229 | 0.0229 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0047 | 0.0229 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.1054 | 1 |
Onchocerca volvulus | 0.0093 | 0.0734 | 0.8785 | |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0029 | 0.0039 | 0.0147 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0035 | 0.0107 | 0.0107 |
Mycobacterium ulcerans | hypothetical protein | 0.0047 | 0.0239 | 0.0133 |
Trypanosoma brucei | trypanothione reductase | 0.0047 | 0.0229 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0047 | 0.0239 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0036 | 0.0109 | 0.4754 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0047 | 0.0239 | 0.1374 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0035 | 0.0107 | 0.0021 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0106 | 0.0881 | 0.0802 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0939 | 1 | 1 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0047 | 0.0239 | 0.0133 |
Echinococcus granulosus | tumor protein p63 | 0.0676 | 0.7121 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.